1268 related articles for article (PubMed ID: 22169458)
1. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
[TBL] [Abstract][Full Text] [Related]
2. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
[TBL] [Abstract][Full Text] [Related]
4. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group.
Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP
Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database.
Lescoat A; Huang S; Carreira PE; Siegert E; de Vries-Bouwstra J; Distler JHW; Smith V; Del Galdo F; Anic B; Damjanov N; Rednic S; Ribi C; Bancel DF; Hoffmann-Vold AM; Gabrielli A; Distler O; Khanna D; Allanore Y;
JAMA Dermatol; 2023 Aug; 159(8):837-847. PubMed ID: 37378994
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differences.
Simeón-Aznar CP; Tolosa-Vilella C; Gabarró-Juliá L; Campillo-Grau M; Guillén Del Castillo A; Fonollosa-Plá V; Vilardell-Tarrés M
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-33-40. PubMed ID: 24776173
[TBL] [Abstract][Full Text] [Related]
7. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
8. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry.
Marí-Alfonso B; Simeón-Aznar CP; Guillén-Del Castillo A; Rubio-Rivas M; Trapiella-Martínez L; Todolí-Parra JA; Rodríguez Carballeira M; Marín-Ballvé A; Iniesta-Arandia N; Colunga-Argüelles D; Castillo-Palma MJ; Sáez-Comet L; Egurbide-Arberas MV; Ortego-Centeno N; Freire M; Vargas Hitos JA; Chamorro AJ; Madroñero-Vuelta AB; Perales-Fraile I; Pla-Salas X; Fernández-De-La-Puebla RA; Fonollosa-Pla V; Tolosa-Vilella C; ;
Semin Arthritis Rheum; 2018 Jun; 47(6):849-857. PubMed ID: 29246416
[TBL] [Abstract][Full Text] [Related]
10. Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology.
De Angelis R; Ferri C; Giuggioli D; Bajocchi G; Dagna L; Bellando-Randone S; Zanframundo G; Foti R; Cacciapaglia F; Cuomo G; Ariani A; Rosato E; Lepri G; Girelli F; Riccieri V; Zanatta E; Bosello SL; Cavazzana I; Ingegnoli F; De Santis M; Murdaca G; Abignano G; Romeo N; Della Rossa A; Caminiti M; Iuliano AM; Ciano G; Beretta L; Bagnato G; Lubrano E; De Andres I; Giollo A; Saracco M; Agnes C; Cipolletta E; Lumetti F; Spinella A; Magnani L; Campochiaro C; De Luca G; Codullo V; Visalli E; Di Vico C; Gigante A; Pellagrino G; Pigatto E; Lazzaroni MG; Franceschini F; Generali E; Mennillo G; Barsotti S; Mariano GP; Furini F; Vultaggio L; Parisi S; Peroni CL; Rozza D; Zanetti A; Carrara G; Landolfi G; Scirè CA; Bianchi G; Fusaro E; Sebastiani GD; Govoni M; D'Angelo S; Cozzi F; Guiducci S; Doria A; Salvarani C; Iannone F; Matucci-Cerinic M;
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36868782
[TBL] [Abstract][Full Text] [Related]
11. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
[TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
Poormoghim H; Lucas M; Fertig N; Medsger TA
Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
[TBL] [Abstract][Full Text] [Related]
13. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
[TBL] [Abstract][Full Text] [Related]
14. Systemic sclerosis sine scleroderma: distinct features in a large Brazilian cohort.
Marangoni RG; Rocha LF; Del Rio AP; Yoshinari NH; Marques-Neto JF; Sampaio-Barros PD
Rheumatology (Oxford); 2013 Aug; 52(8):1520-4. PubMed ID: 23661427
[TBL] [Abstract][Full Text] [Related]
15. The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.
Vanthuyne M; Smith V; De Langhe E; Van Praet J; Arat S; Depresseux G; Westhovens R; Blockmans D; Badot V; Cogan E; De Keyser F; Houssiau FA
J Rheumatol; 2012 Nov; 39(11):2127-33. PubMed ID: 22984273
[TBL] [Abstract][Full Text] [Related]
16. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
Perera A; Fertig N; Lucas M; Rodriguez-Reyna TS; Hu P; Steen VD; Medsger TA
Arthritis Rheum; 2007 Aug; 56(8):2740-6. PubMed ID: 17665460
[TBL] [Abstract][Full Text] [Related]
17. Peripheral vasculopathy in patients with systemic sclerosis: difference in limited and diffuse subset of disease.
Ostojić P; Damjanov N; Pavlov-Dolijanovic S; Radunović G
Clin Hemorheol Microcirc; 2004; 31(4):281-5. PubMed ID: 15567898
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis.
Schieir O; Thombs BD; Hudson M; Boivin JF; Steele R; Bernatsky S; Hanley J; Baron M;
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):409-17. PubMed ID: 20391488
[TBL] [Abstract][Full Text] [Related]
19. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
Nihtyanova SI; Tang EC; Coghlan JG; Wells AU; Black CM; Denton CP
QJM; 2010 Feb; 103(2):109-15. PubMed ID: 19966313
[TBL] [Abstract][Full Text] [Related]
20. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
Liakouli V; Manetti M; Pacini A; Tolusso B; Fatini C; Toscano A; Cipriani P; Guiducci S; Bazzichi L; Codullo V; Ruocco L; Dell'orso L; Carubbi F; Marrelli A; Abbate R; Bombardieri S; Ferraccioli G; Montecucco C; Valentini G; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
Ann Rheum Dis; 2009 Apr; 68(4):584-90. PubMed ID: 18445624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
